The Department of Science and Technology said Friday, Jan. 7, that more than 5,900 participants of the World Health Organization’s Solidarity Trial for Vaccines in the country have already received their first dose of vaccines against coronavirus disease .
DOST Undersecretary for Research and Development Dr. Rowena Cristina L. Guevara said as of Jan. 3, a total of 5,901 participants have been inoculated with the first dose of COVID-19 vaccine, while 3,840 participants have completed their two-dose regimen. “As of January 3, 2022, eight hospitals and two community-based sites have already conducted the recruitment activities with a total of 5,901 have already been vaccinated with first dose and 3,840 participants have already completed the two-dose schedule of the first study vaccine,” she told the Manila Bulletin in an interview.
The lead investigators of the trial are Dr. Jodor A. Lim and Dr. Marissa M. Alejandria of the University of the Philippines Manila-Philippine General Hospital . Guevara explained that the WHO-coordinated global study “Solidarity Trial Vaccines” is implemented locally through the project “Solidarity Vaccine Trial in the Philippines: Randomized Trial of Candidate Vaccines for COVID-19”.Philippine General Hospital St. Luke’s Medical Center The project team is eyeing to enroll 15,000 to 20,000 Filipinos aged 16 and above to participate in the trial.Guevara said the study “will continue to run until the second quarter of 2022.